Bank Of New York Mellon Corp Kezar Life Sciences, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$6.39 - $8.8 $1.16 Million - $1.6 Million	182,197 New	182,197 $1.28 Million
Q3 2022 Nov 14, 2022	BUY	$7.99 - $10.75 $270,589 - $364,059	33,866 Added 22.88%	181,850 $1.57 Million
Q2 2022 Aug 15, 2022	SELL	$4.58 - $17.13 $196,967 - $736,692	-43,006 Reduced 22.52%	147,984 $1.22 Million
Q1 2022 May 11, 2022	SELL	$12.3 - $18.33 $10,344 - $15,415	-841 Reduced 0.44%	190,990 $3.17 Million
Q4 2021 Feb 11, 2022	BUY	$7.44 - $16.72 $509,669 - $1.15 Million	68,504 Added 55.55%	191,831 $3.21 Million
Q3 2021 Nov 12, 2021	BUY	$4.85 - $9.73 $53,995 - $108,324	11,133 Added 9.92%	123,327 $1.07 Million
Q2 2021 Aug 11, 2021	BUY	$4.93 - $6.46 $5,689 - $7,454	1,154 Added 1.04%	112,194 $609,000
Q1 2021 May 13, 2021	SELL	$5.24 - $6.99 $8,488 - $11,323	-1,620 Reduced 1.44%	111,040 $661,000
Q4 2020 Feb 09, 2021	BUY	$4.77 - $6.58 $372 - $513	78 Added 0.07%	112,660 $588,000
Q3 2020 Nov 12, 2020	BUY	$4.36 - $5.5 $47,353 - $59,735	10,861 Added 10.68%	112,582 $544,000
Q2 2020 Aug 12, 2020	BUY	$3.6 - $7.75 $19,141 - $41,206	5,317 Added 5.52%	101,721 $526,000
Q1 2020 May 06, 2020	BUY	$2.77 - $5.75 $133,887 - $277,926	48,335 Added 100.55%	96,404 $420,000
Q4 2019 Feb 14, 2020	SELL	$2.5 - $4.26 $3,810 - $6,492	-1,524 Reduced 3.07%	48,069 $192,000
Q3 2019 Nov 07, 2019	SELL	$3.0 - $7.58 $7,515 - $18,987	-2,505 Reduced 4.81%	49,593 $162,000
Q2 2019 Aug 12, 2019	BUY	$7.09 - $21.9 $132,930 - $410,603	18,749 Added 56.22%	52,098 $402,000
Q1 2019 May 14, 2019	BUY	$16.83 - $23.75 $268,017 - $378,218	15,925 Added 91.4%	33,349 $592,000
Q4 2018 Feb 11, 2019	BUY	$20.21 - $32.9 $352,139 - $573,249	17,424 New	17,424 $411,000

Others Institutions Holding KZR

# of Institutions

Shares Held

38.2M

Call Options Held

13.8K

Put Options Held

600

Suvretta Capital Management, LLC New York, NY

7.17M
Shares

$45.4 Million
0.22% of portfolio
Avidity Partners Management LP Dallas, TX

5.03M
Shares

$31.9 Million
0.24% of portfolio
Tang Capital Management LLC San Diego, CA

3.64M
Shares

$23.1 Million
0.24% of portfolio
Vanguard Group Inc Valley Forge, PA

2.74M
Shares

$17.4 Million
0.0% of portfolio
Affinity Asset Advisors, LLC New York, NY

2.51M
Shares

$15.9 Million
0.33% of portfolio

View Full List

About Kezar Life Sciences, Inc.

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $433M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

More about KZR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account